Phase I/II trial of carboplatin (CBDCA)/weekly paclitaxel in patients with advanced non-small cell lung cancer in Japanese population: WJTOG 9907

被引：0
|
作者：
Bessho, A [1 ]
Saka, H [1 ]
Kitaguchi, S [1 ]
Yamamoto, M [1 ]
Shinkai, T [1 ]
Fukuoka, M [1 ]
Ariyoshi, Y [1 ]
机构：
[1] Natl Hosp Org, Shikoku Canc Ctr, Shikoku, Ehime, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S236 / S236
页数：1
相关论文
共 50 条
  • [1] Phase I/II trial of carboplatin (CBDCA)/weekly paclitaxel in patients with advanced non-small cell lung cancer in Japanese population: WJTOG 9907.
    Saka, H
    Nogami, N
    Kitaguchi, S
    Yamamoto, M
    Fukuoka, M
    Ariyoshi, Y
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 705S - 705S
  • [2] A phase II trial of weekly paclitaxel and carboplatin for elderly patients with advanced non-small cell lung cancer (NSCLC).
    Usui, K
    Inoue, A
    Ishimoto, O
    Tanaka, M
    Koinumaru, S
    Matsubara, N
    Kanbe, M
    Gomi, K
    Saijo, Y
    Nukiwa, T
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 682S - 682S
  • [3] Phase I/II study of carboplatin and weekly paclitaxel for advanced non-small cell lung cancer.
    Ohashi, N
    Arita, KI
    Daga, H
    Mito, A
    Nishino, R
    Moritani, C
    Nakamura, K
    Daido, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 687S - 687S
  • [4] Phase II study of carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
    Nakadate, Megumi
    Yamazaki, Koichi
    Konishi, Jun
    Kinoshita, Ichiro
    Sukoh, Noriaki
    Harada, Masao
    Akie, Kenji
    Ogura, Shigeaki
    Ishida, Takashi
    Munakata, Mitsuru
    Dosaka-Akita, Hirotoshi
    Isobe, Hiroshi
    Nishimura, Masaharu
    ANTICANCER RESEARCH, 2006, 26 (5B) : 3767 - 3772
  • [5] Phase I trial of carboplatin and weekly paclitaxel in patients with advanced non-small-cell lung cancer
    Kikuchi, J
    Yamazaki, K
    Kinoshita, I
    Asahina, H
    Imura, M
    Kikuchi, E
    Konishi, J
    Shinagawa, N
    Oki, H
    Dosaka-Akita, H
    Nishimura, M
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (09) : 505 - 509
  • [6] A phase I/II study of bexarotene with carboplatin and weekly paclitaxel for the treatment of patients with advanced non-small cell lung cancer
    Dragnev, Konstantin H.
    Whyman, Jeremy D.
    Hahn, Cynthia K.
    Kebbekus, Peter E.
    Kokko, Sarah F.
    Bhatt, Sunil M.
    Rigas, James R.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (09) : 5531 - 5537
  • [7] A PHASE I/II STUDY OF BEXAROTENE WITH WEEKLY PACLITAXEL AND CARBOPLATIN FOR THE TREATMENT OF PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Whyman, Jeremy D.
    Kebbekus, Peter E.
    Fink, Sarah K.
    Rigas, James R.
    Dragnev, Konstantin H.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S883 - S883
  • [8] A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer
    Kelly, K
    Mikhaeel-Kamel, N
    Pan, ZX
    Murphy, J
    Prindiville, S
    Bunn, PA
    CLINICAL CANCER RESEARCH, 2000, 6 (09) : 3474 - 3479
  • [9] A phase I trial of paclitaxel, carboplatin, and gemcitabine in advanced non-small cell lung cancer
    Kelly, K
    Prindiville, S
    Bunn, PA
    SEMINARS IN ONCOLOGY, 1999, 26 (01) : 74 - 74
  • [10] A phase II study of weekly paclitaxel combined with carboplatin for elderly patients with advanced non-small cell lung cancer
    Inoue, A
    Usui, K
    Ishimoto, O
    Matsubara, N
    Tanaka, M
    Kanbe, M
    Gomi, K
    Koinumaru, S
    Saijo, Y
    Nukiwa, T
    LUNG CANCER, 2006, 52 (01) : 83 - 87
12345